What is the Future of Proteomic Markers in Cancer Research?
The future of proteomic markers in cancer research is promising. Advances in technology, such as next-generation sequencing and improved bioinformatics tools, are likely to enhance our ability to identify and validate novel biomarkers. Personalized medicine, driven by proteomic data, will become increasingly important, leading to more precise and effective cancer treatments.
